These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 9690059
1. Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital. Müller UA, Müller R, Starrach A, Hunger-Dathe W, Schiel R, Jörgens V, Grüsser M. Diabetes Metab; 1998 Jun; 24(3):251-5. PubMed ID: 9690059 [Abstract] [Full Text] [Related]
2. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R. Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087 [Abstract] [Full Text] [Related]
3. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy. Schiel R, Ulbrich S, Müller UA. Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217 [Abstract] [Full Text] [Related]
4. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up]. Rosendal H, Vondeling H, de Witte LP, Hutubessy RC, van Beekum WT, Heine RJ. Ned Tijdschr Geneeskd; 2002 Jan 26; 146(4):166-71. PubMed ID: 11845567 [Abstract] [Full Text] [Related]
5. Initiating insulin treatment in insulin-requiring type 2 diabetic patients: comparative efficiency and cost of outpatient and inpatient management. INNOV Study Group. Penfornis A, Millot L. Diabetes Metab; 1998 Apr 26; 24(2):137-42. PubMed ID: 9592638 [Abstract] [Full Text] [Related]
6. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group. Schiel R, Müller UA, Rauchfub J, Sprott H, Müller R. Diabetes Metab; 1999 Sep 26; 25(4):334-40. PubMed ID: 10566123 [Abstract] [Full Text] [Related]
7. [Cost effectiveness and evaluation of a structured therapy and education program for insulin-treated type II diabetic patients in Bradenburg]. Schlottmann N, Grüsser M, Hartmann P, Jörgens V. Z Arztl Fortbild (Jena); 1996 Aug 26; 90(5):441-4. PubMed ID: 9157737 [Abstract] [Full Text] [Related]
8. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses]. Costa B, Estopá A, Borrás J, Sabaté A. Med Clin (Barc); 1998 Nov 07; 111(15):568-72. PubMed ID: 9859089 [Abstract] [Full Text] [Related]
9. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both type 1 and type 2 diabetes. Matteucci E, Giampietro O. Diabetes Nutr Metab; 2003 Nov 07; 16(5-6):298-305. PubMed ID: 15000441 [Abstract] [Full Text] [Related]
10. Inpatient or outpatient initiation of insulin therapy. Experience and cost effective analysis in a suboptimal clinical setting. Mengistu M, Lungi Y, Mamo F. Trop Geogr Med; 1991 Nov 07; 43(1-2):180-3. PubMed ID: 1750112 [Abstract] [Full Text] [Related]
11. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Sulli N, Shashaj B. Diabet Med; 2006 Aug 07; 23(8):900-6. PubMed ID: 16911629 [Abstract] [Full Text] [Related]
12. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss. Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M. Curr Med Res Opin; 2005 Nov 07; 21(11):1885-90. PubMed ID: 16307710 [Abstract] [Full Text] [Related]
13. [Effects of a programme for structured outpatient follow-up care after inpatient rehabilitation of obese children and adolescents--a multicentre, randomized study]. van Egmond-Fröhlich A, Bräuer W, Goldschmidt H, Hoff-Emden H, Oepen J, Zimmermann E. Rehabilitation (Stuttg); 2006 Feb 07; 45(1):40-51. PubMed ID: 16468112 [Abstract] [Full Text] [Related]
14. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone. Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA. Diabet Med; 2007 Jul 07; 24(7):778-83. PubMed ID: 17535290 [Abstract] [Full Text] [Related]
15. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy. Habib SS, Aslam M, Naveed AK, Razi MS. Saudi Med J; 2006 Feb 07; 27(2):174-80. PubMed ID: 16501671 [Abstract] [Full Text] [Related]
16. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study. Meneghini L, Koenen C, Weng W, Selam JL. Diabetes Obes Metab; 2007 Nov 07; 9(6):902-13. PubMed ID: 17924873 [Abstract] [Full Text] [Related]
17. [Evaluation of an intensive treatment education program for type 1 diabetes in a group of adolescents. A two year follow up]. Krochik AG, Mazza CS, Araujo MB, Kovalskys I, Ozuna B, Assad D, Coppola L, Domenech I, Lahera E, Zufriategui Z, Gagliardino JJ. Medicina (B Aires); 2004 Nov 07; 64(2):107-12. PubMed ID: 15628295 [Abstract] [Full Text] [Related]
18. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy. Rosenstock J, Einhorn D, Hershon K, Glazer NB, Yu S, Pioglitazone 014 Study Group. Int J Clin Pract; 2002 May 07; 56(4):251-7. PubMed ID: 12074206 [Abstract] [Full Text] [Related]
19. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller UA. Diabetes Care; 2006 Oct 07; 29(10):2196-9. PubMed ID: 17003292 [Abstract] [Full Text] [Related]
20. Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting. Kuniss N, Müller UA, Kloos C, Müller R, Starrach G, Jörgens V, Kramer G. Acta Diabetol; 2018 Feb 07; 55(2):131-137. PubMed ID: 29149381 [Abstract] [Full Text] [Related] Page: [Next] [New Search]